Skip to content
Riskpilot
← Back to search
Sign in
Get full access
OrfoNeuro ApS
APS
Active
CVR 37768901
Bjergagervej 37, 3540
Lynge
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2016 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
OrfoNeuro ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-79
-90
-148
-199
-268
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-79
-90
-148
-199
-268
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-79
-90
-148
-199
-268
Net financials
-16
-19
-31
-43
-22
Profit before tax
-96
-109
-179
-243
-290
Tax
-7
-14
30
-0
-0
Net profit
-88
-95
-208
-243
-290
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
46
53
47
28
82
Equity
-504
-599
-808
-1.050
10
Long-term debt
539
641
828
1.063
0
Short-term debt
12
12
27
14
72
Total debt
550
652
855
1.078
72
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-26755800.0%
This company
2021
2025
Equity ratio
11.7%
This company
38.2%
Market median
-69% vs market
2021
2025
Return on equity
-3035.4%
This company
18.4%
Market median
-16597% vs market
2021
2025
Net profit margin (of gross profit)
-28972900.0%
This company
2021
2025
Asset turnover (of gross profit)
-3.27×
This company
2021
2025
Debt / equity
7.58×
This company
0.62×
Market median
-1123% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on OrfoNeuro ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
